DE60009665D1 - Zusammensetzungen zur behandlung von entzündungsreaktionen - Google Patents

Zusammensetzungen zur behandlung von entzündungsreaktionen

Info

Publication number
DE60009665D1
DE60009665D1 DE60009665T DE60009665T DE60009665D1 DE 60009665 D1 DE60009665 D1 DE 60009665D1 DE 60009665 T DE60009665 T DE 60009665T DE 60009665 T DE60009665 T DE 60009665T DE 60009665 D1 DE60009665 D1 DE 60009665D1
Authority
DE
Germany
Prior art keywords
compositions
treating
ignition reactions
ignition
reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009665T
Other languages
English (en)
Other versions
DE60009665T2 (de
Inventor
Joel M Linden
Gail W Sullivan
Ian J Sarembock
Timothy Macdonald
Mark Okusa
Irving L Kron
W Michael Scheld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia UVA
Original Assignee
University of Virginia UVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/333,387 external-priority patent/US6232297B1/en
Application filed by University of Virginia UVA filed Critical University of Virginia UVA
Publication of DE60009665D1 publication Critical patent/DE60009665D1/de
Application granted granted Critical
Publication of DE60009665T2 publication Critical patent/DE60009665T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60009665T 1999-02-01 2000-01-31 Zusammensetzungen zur behandlung von entzündungsreaktionen Expired - Lifetime DE60009665T2 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US11802999P 1999-02-01 1999-02-01
US118029P 1999-02-01
US12431699P 1999-03-12 1999-03-12
US124316P 1999-03-12
US13337499P 1999-05-10 1999-05-10
US133374P 1999-05-10
US13557399P 1999-05-24 1999-05-24
US135573P 1999-05-24
US333387 1999-06-15
US09/333,387 US6232297B1 (en) 1999-02-01 1999-06-15 Methods and compositions for treating inflammatory response
US15141299P 1999-08-30 1999-08-30
US151412P 1999-08-30
PCT/US2000/002324 WO2000044763A2 (en) 1999-02-01 2000-01-31 Compositions for treating inflammatory response

Publications (2)

Publication Number Publication Date
DE60009665D1 true DE60009665D1 (de) 2004-05-13
DE60009665T2 DE60009665T2 (de) 2004-08-19

Family

ID=27557920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009665T Expired - Lifetime DE60009665T2 (de) 1999-02-01 2000-01-31 Zusammensetzungen zur behandlung von entzündungsreaktionen

Country Status (26)

Country Link
EP (1) EP1150991B1 (de)
JP (1) JP4837831B2 (de)
KR (1) KR100668006B1 (de)
CN (1) CN1191266C (de)
AR (1) AR029332A1 (de)
AT (1) ATE263777T1 (de)
AU (2) AU778870B2 (de)
BR (1) BR0007864A (de)
CA (1) CA2361614C (de)
CZ (1) CZ296404B6 (de)
DE (1) DE60009665T2 (de)
DK (1) DK1150991T3 (de)
EE (1) EE05185B1 (de)
ES (1) ES2215609T3 (de)
HK (1) HK1047288A1 (de)
HU (1) HU228937B1 (de)
IL (2) IL144188A0 (de)
MX (1) MXPA01007850A (de)
MY (1) MY129445A (de)
NO (1) NO321216B1 (de)
NZ (1) NZ513096A (de)
PL (1) PL199953B1 (de)
PT (1) PT1150991E (de)
SK (1) SK284877B6 (de)
UA (1) UA72912C2 (de)
WO (1) WO2000044763A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7214665B2 (en) 2001-10-01 2007-05-08 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
US7427606B2 (en) 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
EP1740587A4 (de) * 2004-04-02 2009-07-15 Adenosine Therapeutics Llc Selektive antagonisten von a2a-adenosinrezeptoren
JP2007536241A (ja) * 2004-05-03 2007-12-13 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性腎症の処置のためのａ２ａアデノシンレセプターアゴニスト
US7442687B2 (en) 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
EP1778712B1 (de) 2004-08-02 2013-01-30 University Of Virginia Patent Foundation 2-propynyl-adenosin-analoga mit modifizierten 5'-ribosegruppen mit a2a-agonistenaktivität
US8178509B2 (en) 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
WO2007107598A1 (en) 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
MY161655A (en) * 2008-07-03 2017-04-28 Univ Virginia Patent Foundation Unit dosage of apadenoson
KR20120107065A (ko) 2009-06-30 2012-09-28 포레스트 래보러토리즈 홀딩스 리미티드 Ａ２ａｒ 효현제용 알콕시 카르보닐 아미노 알키닐 아데노신 화합물 및 그 유도체
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
WO2020253867A1 (zh) * 2019-06-21 2020-12-24 中国人民解放军军事科学院军事医学研究院 具有a2a腺苷受体拮抗作用的小分子化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537228A1 (de) * 1985-10-19 1987-04-23 Huels Chemische Werke Ag Verfahren zur herstellung von cyclohexylverbindungen
JPS6299330A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 抗高血圧剤
KR0137786B1 (ko) * 1988-11-15 1998-05-15 하마구찌 미찌오 심장 또는 뇌의 허혈성 질환의 치료, 예방제
DE69022176T2 (de) * 1989-06-20 1996-02-15 Toa Eiyo Ltd., Tokio/Tokyo Zwischenverbindung für 2-alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2-alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.
WO1991009864A1 (en) * 1990-01-04 1991-07-11 Yamasa Shoyu Kabushiki Kaisha Drug for treating or preventing ischemic diseases of heart or brain
JPH03287537A (ja) * 1990-03-31 1991-12-18 Yamasa Shoyu Co Ltd 抗動脈硬化症剤
JP3025559B2 (ja) * 1990-07-19 2000-03-27 ヤマサ醤油株式会社 アデノシン誘導体
JP3053908B2 (ja) * 1991-06-28 2000-06-19 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
JP3025557B2 (ja) * 1991-06-28 2000-03-27 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
EP0983768A1 (de) * 1997-05-23 2000-03-08 Nippon Shinyaku Co., Ltd. Arzneimittel zur vorbeugung bzw. zur behandlung von leberleiden
AU740770B2 (en) * 1997-06-18 2001-11-15 Aderis Pharmaceuticals, Inc. Compositions and methods for preventing restenosis following revascularization procedures
JPH11335302A (ja) * 1998-05-26 1999-12-07 Toa Eiyo Ltd 安定な医薬組成物
JP3619017B2 (ja) * 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物

Also Published As

Publication number Publication date
HU228937B1 (en) 2013-06-28
AU2005201255B2 (en) 2008-02-28
ES2215609T3 (es) 2004-10-16
WO2000044763A2 (en) 2000-08-03
EE200100397A (et) 2002-08-15
ATE263777T1 (de) 2004-04-15
CA2361614E (en) 2000-08-03
PT1150991E (pt) 2004-08-31
WO2000044763A3 (en) 2000-12-14
BR0007864A (pt) 2001-11-06
PL199953B1 (pl) 2008-11-28
UA72912C2 (uk) 2005-05-16
DK1150991T3 (da) 2004-06-07
AU2005201255A1 (en) 2005-04-21
JP2002536300A (ja) 2002-10-29
IL144188A (en) 2008-12-29
SK284877B6 (sk) 2006-01-05
CA2361614C (en) 2008-08-26
HK1047288A1 (en) 2003-02-14
CZ20012781A3 (cs) 2002-01-16
EP1150991B1 (de) 2004-04-07
NO20013507D0 (no) 2001-07-13
CN1191266C (zh) 2005-03-02
AR029332A1 (es) 2003-06-25
AU2745400A (en) 2000-08-18
HUP0200224A2 (en) 2002-06-29
IL144188A0 (en) 2002-05-23
HUP0200224A3 (en) 2005-02-28
EP1150991A2 (de) 2001-11-07
KR20020013494A (ko) 2002-02-20
JP4837831B2 (ja) 2011-12-14
CA2361614A1 (en) 2000-08-03
SK10972001A3 (sk) 2002-01-07
AU778870B2 (en) 2004-12-23
CN1357002A (zh) 2002-07-03
CZ296404B6 (cs) 2006-03-15
NZ513096A (en) 2003-01-31
EE05185B1 (et) 2009-06-15
DE60009665T2 (de) 2004-08-19
MXPA01007850A (es) 2002-08-20
KR100668006B1 (ko) 2007-01-15
NO321216B1 (no) 2006-04-03
NO20013507L (no) 2001-09-18
MY129445A (en) 2007-04-30

Similar Documents

Publication Publication Date Title
DE60009665D1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60117977D1 (de) Vorrichtungen zur behandlung von harninkontinenz
DE69812603T2 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE69910781D1 (de) Behandlung zur beseitigung von gerüchen
ATE477270T1 (de) Verfahren und zusammensetzungen zur prävention und behandlung von anämie
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69922226D1 (de) Vorrichtung zur behandlung von ischämie
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
ATE222910T1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition